FULL PAPER
ppm. MS (ES+): m/z (%) = 386.95 (50) [M + H]. C18H11BrSe
(386.15): calcd. C 56.0, H 2.9; found C 55.9, H 2.85.
(s), 130.6 (s), 129.6 (s, CH), 127.9 (s, CH), 125.6 (s), 120.7 (q),
118.8 (q), 97.7 (q) ppm. 125Te NMR (81.2 MHz, CDCl3, 25 °C,
MeTeTeMe): δ = 687 (s) ppm. MS (ES+): m/z (%) = 512.91 (95)
[M + OMe]. C18H11ITe (481.79): calcd. C 44.9, H 2.3; found C
44.9, H 2.3.
[Acenapyl(TePh)(Br)] (3): Compound 3 was synthesised by the
method described for 13 but with DDQ (0.57 g, 2.49 mmol) and
[Acenap(TePh)(Br)] A3 (0.73 g, 1.66 mmol) to yield an orange so-
lid, which was recrystallised by diffusion of hexane into a saturated
solution of the compound in dichloromethane to give red crystals
(0.17 g, 23%); m.p. 105–107 °C. 1H NMR (300 MHz, CDCl3,
[Acenapyl(SPh)2] (7): Compound 7 was synthesised by the method
described for 13 but with DDQ (0.93 g, 4.11 mmol) and [Acenap-
(SPh)2] A7 (1.04 g, 2.81 mmol) to afford a dark yellow solid (0.61 g,
25 °C, Me4Si): δ = 7.91–7.86 (m, 2 H, TePh 12,16-H), 7.67 [d, 3JH,H 58%); m.p. 169–171 °C. 1H NMR (300 MHz, CDCl3, 25 °C,
= 7.3 Hz, 1 H, Acenapyl 4-H], 7.42–7.36 (m, 1 H, TePh 14-H), Me4Si): δ = 7.38 [d, JH,H = 7.3 Hz, 2 H, Acenapyl 4,7-H], 7.33–
3
3
7.33–7.25 (m, 3 H, Acenapyl 3-H, TePh 13,15-H), 7.23 [d, JH,H
=
7.16 (m, 12 H, Acenapyl 3,8-H, SPh 12–16-H), 6.87 (s, 2 H, Acena-
pyl 9,10-H) ppm. 13C NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ
= 148.2 (q), 136.4 (q), 132.6 (s), 132.4 (s), 131.1 (q), 129.8 (s), 129.6
(q), 129.0 (s, CHϫ2), 127.9 (s), 127.0 (q), 125.0 (s), 120.8 (q) ppm.
7.4 Hz, 1 H, Acenapyl 7-H], 7.08 [d, 3JH,H = 7.4 Hz, 1 H, Acenapyl
3
3
8-H], 6.81 [d, JH,H = 5.3 Hz, 1 H, CH], 6.74 [d, JH,H = 5.3 Hz, 1
H, CH] ppm. 13C NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ =
141.9 (s), 141.1 (q), 139.3 (q), 135.0 (s), 133.1 (s), 131.8 (q), 130.6 MS (ES+): m/z (%) = 390.79 (100) [M + Na]. C24H16S2 (368.51):
(s), 129.7 (s), 129.5 (s), 127.8 (s, CH), 125.6 (s, CH), 125.0 (s), 123.4
(q), 121.8 (q), 118.8 (q), 30.5 (q) ppm. 125Te NMR (81.2 MHz,
CDCl3, 25 °C, MeTeTeMe): δ = 724 (s) ppm. MS (ES+): m/z (%)
= 466.87 (100) [M + OMe], 435.90 (40), [M + H]. C18H11BrTe
(434.79): calcd. C 49.7, H 2.6; found C 49.6, H 2.6.
calcd. C 78.2, H 4.4; found C 78.1, H 4.5.
[Acenapyl(SePh)2] (8): Compound 8 was synthesised by the method
described for 13 but with DDQ (0.74 g, 3.26 mmol) and [Acenap-
(SePh)2] A8 (1.01 g, 2.16 mmol) to yield an orange solid, which was
recrystallised from diffusion of hexane into a saturated solution of
the compound in dichloromethane to give orange crystals (0.53 g,
[Acenapyl(SPh)(I)] (4): Compound 4 was synthesised by the
method described for 13 but with DDQ (0.41 g, 1.81 mmol) and
[Acenap(SPh)(I)] A4 (0.46 g, 1.19 mmol) to yield a brown oil
1
53%); m.p. 82–84 °C. H NMR (300 MHz, CDCl3, 25 °C, Me4Si):
3
δ = 7.73–7.69 (m, 2 H, SePh 12,16-H), 7.67 [d, JH,H = 7.7 Hz, 2
(0.17 g, 37%). 1H NMR (300 MHz, CDCl3, 25 °C, Me4Si): δ = 8.38 H, Acenapyl 3,8-H], 7.50 [d, JH,H = 7.7 Hz, 2 H, Acenapyl 4,7-
3
[d, 3JH,H = 7.3 Hz, 1 H, Acenapyl 4-H], 7.60–7.38 (m, 7 H, Acena-
H], 7.46–7.44 (m, 3 H, SePh 13–15-H), 7.05 (s, 2 H, Acenapyl 9,10-
H) ppm. 13C NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ = 140.3
(q), 135.05 (s), 134.7 (s), 134.3 (q), 133.6 (q), 131.4 (q), 131.2 (q),
130.2 (s), 129.2 (s, CHϫ2), 128.5 (s), 125.3 (s) ppm. 77Se NMR
(51.5 MHz, CDCl3; 25 °C, MeSeSeMe): δ = 428 (s) ppm. MS
(ES+): m/z (%) = 463.78 (100) [M + H]. C24H16Se2 (462.31): calcd.
C 62.4, H 3.5; found C 62.3, H 3.55.
3
pyl 7,8-H, SPh 12–16-H), 7.30 [d, JH,H = 7.3 Hz, 1 H, Acenapyl
3
3
3-H], 7.05 [d, JH,H = 5.3 Hz, 1 H, CH], 6.99 [d, JH,H = 5.3 Hz, 1
H, CH] ppm. 13C NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ =
143.9 (s), 141.3 (q), 140.8 (q), 137.1 (q), 136.8 (q), 134.1 (s), 132.2
(s), 131.1 (q), 130.2 (s), 129.7 (q), 129.5 (s, CH), 129.4 (s, CH),
128.0 (s), 126.0 (s), 125.42 (s), 92.5 (q) ppm. MS (ES+): m/z (%) =
259.03 (100) [M – I]. C18H11BrS (339.25): calcd. C 56.0, H 2.9;
found C 55.9, H 2.8.
[Acenapyl(TePh)2] (9): Compound 9 was synthesised by the method
described for 13 but with DDQ (0.30 g, 1.32 mmol) and [Acenap-
(TePh)2] A9 (0.50 g, 0.89 mmol) to yield a red solid which was
recrystallised by evaporation of dichloromethane to afford red crys-
[Acenapyl(SePh)(I)] (5): Compound 5 was synthesised by the
method described for 13 but with DDQ (0.18 g, 0.78 mmol) and
[Acenap(SePh)(I)] A5 (0.22 g, 0.51 mmol) to yield an orange solid,
which was recrystallised by diffusion of hexane into a saturated
solution of the compound in dichloromethane to give yellow crys-
tals (0.08 g, 34%); m.p. 83–85 °C. 1H NMR (300 MHz, CDCl3,
1
tals (0.22 g, 45%); m.p. 123–125 °C. H NMR (300 MHz, CDCl3,
3
25 °C, Me4Si): δ = 7.80 [d, JH,H = 7.2 Hz, 2 H, Acenapyl 4,7-H],
7.69–7.62 (m, 2 H, TePh 12,16-H), 7.23–7.13 (m, 5 H, Acenapyl
3,8-H, TePh 13–15-H), 6.78 (s, 2 H, Acenapyl 9,10-H) ppm. 13C
NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ = 141.4 (s), 138.6 (s),
3
25 °C, Me4Si): δ = 8.10 [d, JH,H = 7.3 Hz, 1 H, Acenapyl 4-H],
7.55–7.52 (m, 2 H, SePh 12,16-H), 7.32–7.23 (m, 3 H, SePh 13–15- 136.4 (q), 131.0 (q), 130.2 (s), 129.2 (s, CHϫ2), 128.6 (s), 125.3
H), 7.17–7.09 (m, 3 H, Acenapyl 3,7,8-H), 6.75 [d, 3JH,H = 5.3 Hz,
(s), 121.9 (q), 121.6 (q), 120.0 (q) ppm. 125Te NMR (81.2 MHz,
3
1 H, CH], 6.72 [d, JH,H = 5.3 Hz, 1 H, CH] ppm. 13C NMR CDCl3; 25 °C, MeTeTeMe): δ = 618 (s) ppm. 123Te NMR
4
(75.5 MHz, CDCl3, 25 °C, Me4Si): δ = 142.6 (s), 141.3 (q), 139.6
(q), 136.8 (s), 131.9 (s), 131.7 (q), 131.5 (q), 131.2 (q), 130.4 (s),
(70.7 MHz, CDCl3, 25 °C, MeTeTeMe): δ = 619 [s, J(123Te,125Te)
1706] ppm. MS (ES+): m/z (%) = 590.96 (100) [M + OMe], 484.93
129.3 (s, CH), 128.8 (s), 128.3 (s, CH), 125.6 (s), 125.4 (s), 30.2 (q) (62) [M – Ph]. C24H16Te2 (559.59): calcd. C 51.5, H 2.9; found C
ppm. 77Se NMR (51.5 MHz, CDCl3, 25 °C, MeSeSeMe): δ = 427
(s) ppm. MS (ES+): m/z (%) = 464.89 (100) [M + OMe]. C18H11IS
(386.25): calcd. C 49.9, H 2.6; found C 49.8, H 2.6.
51.2, H 3.0.
[Acenapyl(SePh)(SPh)] (10): Compound 10 was synthesised by the
method described for 13 but with DDQ (0.45 g, 1.98 mmol) and
[Acenap(SePh)(SPh)] A10 (0.52 g, 1.25 mmol) to yield an yellow
solid, which was recrystallised from evaporation of dichlorometh-
ane to give red crystals (0.16 g, 31%); m.p. 75–77 °C. 1H NMR
[Acenapyl(TePh)(I)] (6): Compound 6 was synthesised by the
method described for 13 but with DDQ (0.88 g, 3.85 mmol) and
[Acenap(TePh)(I)] A6 (1.22 g, 2.52 mmol) to yield an orange solid,
which was recrystallised by diffusion of hexane into a saturated
solution of the compound in dichloromethane to give orange crys-
3
(300 MHz, CDCl3, 25 °C, Me4Si): δ = 7.88 [d, JH,H = 7.2 Hz, 1
H, Acenapyl 4-H], 7.87–7.82 (m, 2 H, SePh 12,16-H), 7.68 [d, 3JH,H
= 7.2 Hz, 1 H, Acenapyl 3-H], 7.60–7.48 (m, 3 H, SePh 13–15-H),
1
tals (0.87 g, 71%); m.p. 134–136 °C. H NMR (300 MHz, CDCl3,
3
3
25 °C, Me4Si): δ = 8.03 [d, JH,H = 7.3 Hz, 1 H, Acenapyl 4-H],
7.48–7.30 (m, 7 H, Acenapyl 7,8-H, SPh 12–16-H), 7.12 [d, JH,H
3
3
7.85–7.83 (m, 2 H, TePh 12,16-H), 7.66 [d, JH,H = 7.3 Hz, 1 H,
= 5.3 Hz, 1 H, CH], 7.06 [d, JH,H = 5.3 Hz, 1 H, CH] ppm. 13C
Acenapyl 7-H], 7.41–7.21 (m, 4 H, acenapyl 8-H, TePh 13–15 H),
NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ = 142.0 (q), 139.0 (q),
138.6 (q), 137.6 (s), 137.3 (s), 133.1 (q), 131.8 (q), 131.3 (q), 130.7
(s), 130.4 (s, CH), 130.2 (q), 129.8 (s), 129.6 (s), 129.4 (s), 129.0 (s),
128.2 (s, CH), 126.9 (s), 125.7 (s), 124.9 (s) 124.6 (q) ppm. 77Se
NMR (51.5 MHz, CDCl3, 25 °C, MeSeSeMe): δ = 456 (s) ppm.
3
3
7.14 [d, JH,H = 7.3 Hz, 1 H, Acenapyl 3-H], 6.74 [d, JH,H
=
3
5.3 Hz, 1 H, CH], 6.71 [d, JH,H = 5.3 Hz, 1 H, CH] ppm. 13C
NMR (75.5 MHz, CDCl3, 25 °C, Me4Si): δ = 141.9 (s), 141.5 (s),
141.1 (q), 140.0 (q), 139.3 (q), 136.0 (s), 135.0 (s), 133.8 (q), 133.1
Eur. J. Inorg. Chem. 2014, 1512–1523
1521
© 2014 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim